Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1151)	11/25/1998 4:13:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 1722

[Rhone-Poulenc, PFE]11/25 15:56 No science to back EU antibiotic ban -thinktank BRUSSELS, Nov 25 (Reuters) - A Dutch thinktank said on Wednesday a proposed European Union ban on the use of antibiotic growth promoters in livestock because of the effect they could have on humans was not justified on the basis of scientific data. "The gap between the need for some policy concerning the use of antibiotic growth promoters and the lack of factual data concerning direct resistance transfer from animals to humans is bridged by the so-called 'precautionary principle'," Jaap Hanekamp, co-author of a report by Heidelberg Appeal Nederlands (HAN) into growth promoters, said in a statement. The statement was issued by the European Federation of Animal Health and the European Federation of Animal Feed Additive Manufacturers (Fefana). "However, (this) principle...can only serve its function here when reasonable doubts concerning certain human health risks...is substantiated by hard scientific data. In this case, these data are unfortunately lacking," Hanekamp said. The statement said HAN is a non-profit making alliance of scientists and science supporters. Hanekamp said the study was paid for by Fefana. The EU executive European Commission proposed banning four antibiotics in animal feed on November 12. It is to be considered by a panel of EU scientists next month and could take effect in January. Among manufacturers whose sales could be affected by any ban are France's Rhone-Poulenc <RHON.PA> and Pfizer <PFE.N> of the United States.

To: Anthony Wong who wrote (1151)	1/5/1999 11:32:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 1722

Today's Bloomberg has a story on a potential hostile takeover of ZEN by GLX and tomorrow's FT has a couple of merger stories. One is on a hostile takeover of ZEN by GLX or Roche and the other is on more Merger Mania in Europe. Details linked to the Merger Mania tables at biocognizance.com